Successful Treatment of Ulcerative Colitis with Leukocytapheresis Using Non-woven Polyester Filter

Therapeutic Apheresis

Volumn 7, Issue 6, 2003, Pages 536-539

  Sakata, Hiromi ^a   Kawamura, Naoyuki ^a   Horie, Takashi ^a   Ohizumi, Hiroko ^a   Tamaki, Tohru ^a   Kukita, Kazutaka ^a   Meguro, Jun Ichi ^a   Yonekawa, Motoki ^a   Saitoh, Masao ^a   Kawamura, Akio ^a  

^a SAPPORO HOKUYU HOSPITAL   (Japan)

Author keywords

Immunomodulation; Leukocytapheresis; Non woven polyester fiber filter; Ulcerative colitis

Indexed keywords

POLYESTER;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; BLOOD CLOTTING; BLOOD FILTER; BLOOD TRANSFUSION; CELLULAR IMMUNITY; COLONOSCOPY; CYTAPHERESIS; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOMODULATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKAPHERESIS; MALE; MICROPORE FILTERS; MIDDLE AGED; POLYESTERS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0347624664     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2003.00096.x     Document Type: Article

References (19)

1. Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002;359:331-40.
2. Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Buschenfelde KH. T cell specificity and cross reactivity towards enterobacteria, bacterioides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999;44:812-18.
3. Fuss IJ, Neurath M, Boirivant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: Crohn's disease LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-70.
4. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 1998;115:182-205.
5. Amano K, Imazu M, Ezaki H. Therapeutic on-line fiber leukocyte filtration for rheumatoid arthrirts. Artif Organs 1999:14:163-6.
6. Miller FW, Leitman SF, Cronin ME et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-4.
7. Bicks RC, Groshart KW, Chandler RW. The treatment of severe chronically active Crohn's disease by T8 (suppressor cell) lymphapheresis. Gastroenterol 1985;88:A1325.
8. Sawada K, Ohnishi K, Kosaka T et al. Leukocyteapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995;30:124-7.
9. Ayabe T, Ashida T, Kohgo Y. Centrifugal leukocyte apheresis for ulcerative colitis. Ther Apher 1998;2:125-8.
10. Rembacken BJ, Newbould HE, Richards SJ et al. Granulocyte Apheresis in Inflammatory Bowel Disease. Possible Mechanisms of Effect. Ther Apher 1998;2:93-6.
11. Shimoyama T, Sawada K, Hiwatashi N et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
12. Sawada K, Ohnishi K, Kosaka T et al. Leukocyteapheresis with Leukocyte Removal Filter as New Therapy for Ulcerative Colitis. Ther Apher 1997;1:207-11.
13. Kawamura A, Osanai M, Katori M, Yonekawa M, Saitoh M. Basic clinical study of an easy and effective leukocytapheresis by the use of non-woven polyester filter. Ther Apher 1998;2:292-6.
14. Kawamura A, Saitoh M, Yonekawa M et al. New technique of leukocytapheresis by the use of nonwoven polyester fiber filter for inflammatory bowel disease. Ther Apher 1999;3:334-7.
15. Sawada K, Muto T, Shimoyama T et al. Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column. Curr Pharm Des 2003;9:307-21.
16. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-6.
17. Matts SGF. The value of rectal biopsy in the diagnosis of ulcerative colitis. Quart J Med 1961;120:393-407.
18. McCarthy DA, Rampton DS, Liu YC. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol 1991:86:489-93.
19. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.